Potential Cancer Risk with Omalizumab? A Disproportionality Analysis of the Who's Vigibase Pharmacovigilance Database
AuthID
P-00V-5GT
P-00V-5GT
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service